Claims
- 1. A compound of the structure ##STR169## wherein X is a single bond or a straight or branched chain alkylene group of the structure (CH.sub.2).sub.n, wherein n' is 0 to 10, Y is ##STR170## wherein R.sub.7 and R.sub.8 are the same or different and are selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, monocyclic cycloalkyl having 3 to 6 ring members, monocyclic cycloalkyl lower alkyl, wherein the cycloalkyl has 3 to 6 ring members, hydroxy-lower alkyl, phenyl, lower alkylphenyl, acyl radical of a hydrocarbon carboxylic acid of less than 12 carbon atoms, di(lower alkyl)phenyl, halophenyl, mono-, di- or tri-nitrophenyl, phenyl lower alkyl, monocyclic heterocyclic, wherein lower alkyl contains 1 to 8 carbons, R.sub.5 is selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, mono-halo-lower alkyl wherein the halogen is F, Cl, Br or I, acyl radical of a hydrocarbon carboxylic acid of less than 12 carbon atoms, amido, lower alkoxyalkylene and lower alkoxy carbonyl, R.sub.6 is lower alkyl or cycloalkyl having 3 to 6 ring members, and ##STR171## can be taken together to form a heterocyclic radical; wherein the heterocyclic radicals represented by R.sub.7, R.sub.8 or ##STR172## taken together contain 5-, 6- or 7-members in the heterocyclic ring, the ring being pyrrolidine, piperidine, morpholine, thiamorpholine, piperazine or homopiperazine, said pyrrolidine, morpholine, and thiamorpholine rings being optionally substituted with lower alkyl, dilower alkyl or lower alkoxy, said piperidine ring being optionally substituted with lower alkyl, dilower alkyl, lower alkoxy, hydroxy or aminomethyl, said piperazine ring being optionally substituted with lower alkyl, dilower alkyl, lower alkoxy, hydroxy lower alkyl, alkanoyloxy-lower alkyl, hydroxy-lower alkoxy-lower alkyl or carbo-lower alkoxy, and said homopiperazine ring being optionally substituted with hydroxy-lower alkyl, n is 1 to 3; and m is 0, 1 or 2.
- 2. The compound as defined in claim 1 where m is 0.
- 3. The compound as defined in claim 1 wherein X is alkylene.
- 4. The compound as defined in claim 1 wherein Y is piperidine.
- 5. The compound as defined in claim 1 having the name 4,7-dihydro-1-(2-piperidinoethyl)-2-indanol.
- 6. The compound as defined in claim 1 having the name 4,7-dihydro-1-(3-piperidinopropyl)-2-indanol.
- 7. The compound as defined in claim 1 having the name trans-4,7-dihydro-1-[3-(trans-3-hydroxy-4-methylpiperidino)propyl]-2-indanol.
- 8. The compound as defined in claim 1 having the name 1,2-trans-1-[3-(dimethylamino)propyl]-1,2,3,4,5,8-hexahydro-2-naphthol.
- 9. A compound of the structure ##STR173## wherein X is a single bond or a straight or branched chain alkylene group of the structure (CH.sub.2).sub.n, wherein n' is 0 to 10, Y is ##STR174## wherein R.sub.7 and R.sub.8 are the same or different and are selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, monocylic cycloalkyl having 3 to 6 ring members, monocyclic cycloalkyl lower alkyl, wherein the cycloalkyl has 3 to 6 ring members, hydroxy-lower alkyl, phenyl, lower alkylphenyl, acyl radical of a hydrocarbon carboxylic acid of less than 12 carbon atoms, di(lower alkyl)phenyl, halophenyl, mono-, di- or tri-nitrophenyl, phenyl lower alkyl, monocyclic heterocyclic, R.sub.5 is selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, mono-halo-lower alkyl wherein the halogen is F, Cl, Br or I, acyl radical of a hydrocarbon carboxylic acid of less than 12 carbon atoms, amido, lower alkoxyalkylene and lower alkoxy carbonyl, R.sub.6 is lower alkyl or cycloalkyl having 3 to 6 ring members, and ##STR175## can be taken together to form a heterocyclic radical; wherein the heterocyclic radicals represented by R.sub.7, R.sub.8 or ##STR176## taken together contain 5-, 6- or 7-members in the heterocyclic ring, the ring being pyrrolidine, piperidine, morpholine, thiamorpholine, piperazine or homopiperazine, said pyrrolidine, morpholine, and thiamorpholine rings being optionally substituted with lower alkyl, dilower alkyl or lower alkoxy, said piperidine ring being optionally substituted with lower alkyl, dilower alkyl, lower alkoxy, hydroxy or aminomethyl, said piperazine ring being optionally substituted with lower alkyl, dilower alkyl, lower alkoxy, hydroxy lower alkyl, alkanoyloxy-lower alkyl, hydroxy-lower alkoxy-lower alkyl or carbo-lower alkoxy, and said homopiperazine ring being optionally substituted with hydroxy-lower alkyl; n is 1 to 3; and m is 0, 1 and 2.
Parent Case Info
This is a division, of application Ser. No. 820,290, filed July 29, 1977, now U.S. Pat. No. 4,138,497, which is a division of application Ser. No. 649,116, filed Jan. 14, 1976, now U.S. Pat. No. 4,053,596.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
3894031 |
Hauck et al. |
Jul 1975 |
|
3984419 |
Hauck et al. |
Oct 1976 |
|
4053596 |
Hauck et al. |
Oct 1977 |
|
4092318 |
Hauck et al. |
May 1978 |
|
Non-Patent Literature Citations (1)
Entry |
McOmie, J. (Editor), Protective Groups in Organic Chemistry, Plenum Press, New York, 1973, pp. 109 and 117-118. |
Divisions (2)
|
Number |
Date |
Country |
Parent |
820290 |
Jul 1977 |
|
Parent |
649116 |
Jan 1976 |
|